dipyridamole has been researched along with Coronary Thrombosis in 16 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Coronary Thrombosis: Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have reviewed some of the voluminous literature on the effects of aspirin combined with dipyridamole on coronary thrombosis." | 4.78 | Aspirin and dipyridamole and their limitations in the therapy of coronary artery disease. ( Folts, JD; Rowe, GG, 1990) |
| "Dipyridamole was applied in 550 interventions (455 interventions in men, 95 interventions in women, age = 59." | 2.68 | [Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study]. ( Heidland, UE; Heintzen, MP; Kelm, M; Klimek, WJ; Leschke, M; Michel, CJ; Schwartzkopff, B; Strauer, BE; Vester, EG, 1997) |
| "A higher recurrence rate after angioplasty is seen in the presence of a wall thrombus." | 1.27 | [Prevention of thrombosis in the after-care of coronary dilatation and thrombolysis]. ( Lorenz, RL; Schramm, W; Theisen, K; Weber, MA, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gawaz, M | 1 |
| Müller, I | 1 |
| Besta, F | 1 |
| Bochenek, A | 1 |
| Wilczyński, M | 1 |
| Beythien, C | 1 |
| Terres, W | 1 |
| Hamm, CW | 1 |
| Bullough, DA | 1 |
| Zhang, C | 1 |
| Montag, A | 1 |
| Mullane, KM | 1 |
| Young, MA | 1 |
| Danchin, N | 1 |
| Juillière, Y | 1 |
| Kettani, C | 1 |
| Buffet, P | 1 |
| Anconina, J | 1 |
| Cuillière, M | 1 |
| Cherrier, F | 1 |
| Heintzen, MP | 2 |
| Heidland, UE | 2 |
| Klimek, WJ | 1 |
| Michel, CJ | 2 |
| Kelm, M | 1 |
| Leschke, M | 1 |
| Schwartzkopff, B | 1 |
| Vester, EG | 1 |
| Strauer, BE | 2 |
| Schmidt, U | 1 |
| Han, RO | 1 |
| DiSalvo, TG | 1 |
| Guerrero, JL | 2 |
| Gold, HK | 2 |
| Zapol, WM | 1 |
| Bloch, KD | 1 |
| Semigran, MJ | 1 |
| Rowe, GG | 1 |
| Folts, JD | 1 |
| Murohara, Y | 1 |
| Takatsu, Y | 1 |
| Yui, Y | 1 |
| Kawai, C | 1 |
| Pfisterer, M | 1 |
| Burkart, F | 1 |
| Jockers, G | 1 |
| Meyer, B | 1 |
| Regenass, S | 1 |
| Burckhardt, D | 1 |
| Schmitt, HE | 1 |
| Müller-Brand, J | 1 |
| Skarvan, K | 1 |
| Stulz, P | 1 |
| Shalaev, SV | 1 |
| Yasuda, T | 1 |
| Fallon, JT | 1 |
| Leinbach, RC | 1 |
| Scudder, LE | 1 |
| Kanke, M | 1 |
| Shealy, D | 1 |
| Ross, MJ | 1 |
| Collen, D | 1 |
| Coller, BS | 1 |
| Weber, MA | 1 |
| Lorenz, RL | 1 |
| Schramm, W | 1 |
| Theisen, K | 1 |
| Barnathan, ES | 1 |
| Schwartz, JS | 1 |
| Taylor, L | 1 |
| Laskey, WK | 1 |
| Kleaveland, JP | 1 |
| Kussmaul, WG | 1 |
| Hirshfeld, JW | 1 |
| Lavie, CJ | 1 |
| Squires, RW | 1 |
| Gau, GT | 1 |
5 reviews available for dipyridamole and Coronary Thrombosis
| Article | Year |
|---|---|
Combined antithrombotic therapy for acute coronary syndrome.
Topics: Administration, Oral; Angina, Unstable; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; D | 2003 |
[Antiplatelet agents--problem for cardiac surgeon].
Topics: Anticoagulants; Aspirin; Coronary Thrombosis; Dipyridamole; Fibrinolytic Agents; Humans; Myocardial | 2006 |
Aspirin and dipyridamole and their limitations in the therapy of coronary artery disease.
Topics: Animals; Aspirin; Coronary Disease; Coronary Thrombosis; Dipyridamole; Dogs; Drug Therapy, Combinati | 1990 |
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug | 1989 |
Preventive cardiology: what is the value of antiplatelet agents and fish oils?
Topics: Aspirin; Cardiovascular Diseases; Coronary Thrombosis; Dipyridamole; Fish Oils; Humans; Platelet Agg | 1988 |
5 trials available for dipyridamole and Coronary Thrombosis
| Article | Year |
|---|---|
Effect on early acute occlusion rate of adjunctive antithrombotic treatment with intravenously administered dipyridamole during percutaneous transluminal coronary angioplasty.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Aspirin; Chemotherapy, Adjuvant; Coronary Thrombosis; | 1994 |
[Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Coro | 1997 |
Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Thrombosis; Coronar | 2000 |
Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
Topics: 4-Hydroxycoumarins; Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary | 1989 |
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug | 1989 |
7 other studies available for dipyridamole and Coronary Thrombosis
| Article | Year |
|---|---|
In vitro model to test the thrombogenicity of coronary stents.
Topics: Adult; Aspirin; Biocompatible Materials; Coronary Thrombosis; Coronary Vessels; Dipyridamole; Hepari | 1994 |
Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.
Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Aminoimidazole Carboxamide; Animals; Aspirin; Bloo | 1994 |
Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition.
Topics: Administration, Inhalation; Animals; Blood Platelets; Coronary Thrombosis; Dipyridamole; Dogs; Drug | 2001 |
[The mode of action and clinical applications of phosphodiesterase inhibitors as anti-platelet drugs].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cilostazol; Coronary Disease; Coronary Thrombosis; Cyclic AMP; | 1989 |
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.
Topics: Animals; Antibodies, Monoclonal; Aspirin; Coronary Disease; Coronary Thrombosis; Dipyridamole; Dogs; | 1988 |
[Prevention of thrombosis in the after-care of coronary dilatation and thrombolysis].
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Combined Modality Therapy; Coronary Circulation; Coro | 1986 |
Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
Topics: Acute Disease; Angioplasty, Balloon; Aspirin; Coronary Disease; Coronary Thrombosis; Dipyridamole; H | 1987 |